Resilia Pharmaceuticals

Resilia Pharmaceuticals is a privately held specialty pharmaceutical company focused on acquiring and commercializing high-value but underpromoted therapeutics in dermatology. Its lead products include Ecoza® (econazole nitrate) topical foam for tinea pedis, Neosalus® Cream and Lotion for various dermatoses including atopic dermatitis and allergic contact dermatitis, Recedo® Topical Gel for scar management, Neocera® Advanced Cream for skin barrier repair, and Solace® Eczema Cream. The company has relaunched several products that had previously been unavailable due to supply chain disruptions. Clinical results are based on prior regulatory approvals rather than new clinical trials.